Report cover image

Europe Smart Insulin Pens Market Size, Share & Industry Trends Analysis Report By Usability, By Product, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings), By Country and Growth Forecast, 2023 - 2030

Publisher Knowledge Based Value (KBV) Research
Published Nov 30, 2023
Length 146 Pages
SKU # KBV18379982

Description

Europe Smart Insulin Pens Market Size, Share & Industry Trends Analysis Report By Usability, By Product, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings), By Country and Growth Forecast, 2023 - 2030


The Europe Smart Insulin Pens Market would witness market growth of 10.3% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 138.6 thousand units, showcasing a growth of 9.8% (2019-2022).

These pens represent a significant leap forward in diabetes management, offering a range of features that enhance the precision, convenience, and patient engagement associated with insulin therapy. These pens are equipped with advanced technologies, including Bluetooth connectivity, dose tracking, and dose calculation capabilities, that empower patients to better monitor and manage their insulin regimens. By enabling the automatic tracking of insulin doses, these devices simplify record-keeping and offer insightful data that healthcare professionals can analyse to tailor treatment plans to individual patient needs.

Advances in patient adherence, monitoring, and technique have resulted from the development of diabetes management technologies. Insulin pens, for instance, offer a number of benefits over syringes and vials, including better adherence, less pain at the injection site, and increased patient satisfaction. With the increasing number of people with diabetes, second-generation insulin pens have been designed with USB or Bluetooth capabilities for more precise medication monitoring. Likewise, numerous blood glucose self-monitoring gadgets have incorporated Bluetooth technology to facilitate wireless data transfer to smartphones.

Many European healthcare systems are adopting digital health technologies and integrating them into their infrastructure. These pens can be easily incorporated into electronic health records (EHR) and telemedicine platforms, making them an integral part of diabetes management in clinical settings. These policies create an enabling environment for the adoption of these devices. The usage of these pens in Europe is driven by technological advancements, data-driven healthcare, healthcare provider endorsements, supportive policies, personalized medicine, and the region's focus on patient engagement and well-being. As the adoption of these devices continues to grow, they are expected to play an increasingly significant role in improving diabetes management and patient outcomes in Europe.

The Germany market dominated the Europe Smart Insulin Pens Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $12,976 Thousands by 2030. The UK market is exhibiting a CAGR of 9.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 11.2% during (2023 - 2030).

Based on Usability, the market is segmented into Prefilled, and Reusable. Based on Product, the market is segmented into First Generation Pens, and Second Generation Pens (USB Connected, Bluetooth-Enabled). Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Eli Lilly And Company, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Emperra GmbH, Jiangsu Delfu Medical Device Co.,Ltd, Abbott Laboratories and Ypsomed AG

Scope of the Study

Market Segments covered in the Report:

By Usability (Volume, Thousand Units, Revenue, USD Millions, 2019-30)
  • Prefilled
  • Reusable
By Product
  • First Generation Pens
  • Second Generation Pens
  • USB Connected
  • Bluetooth-Enabled
By End User (Volume, Thousand Units, Revenue, USD Millions, 2019-30)
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
By Country (Volume, Thousand Units, Revenue, USD Millions, 2019-30)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Medtronic PLC
  • Eli Lilly And Company
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche Ltd
  • Emperra GmbH
  • Jiangsu Delfu Medical Device Co.,Ltd
  • Abbott Laboratories
  • Ypsomed AG
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

146 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Smart Insulin Pens Market, by Usability
1.4.2 Europe Smart Insulin Pens Market, by Product
1.4.3 Europe Smart Insulin Pens Market, by End User
1.4.4 Europe Smart Insulin Pens Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4 Porter Five Forces Analysis
Chapter 5. Europe Smart Insulin Pens Market, By Usability
5.1 Europe Prefilled Market, By Country
5.2 Europe Reusable Market, By Country
Chapter 6. Europe Smart Insulin Pens Market, By Product
6.1 Europe First Generation Pens Market, By Country
6.2 Europe Second Generation Pens Market, By Country
6.3 Europe Smart Insulin Pens Market, By Second Generation Pens Type
6.3.1 Europe USB Connected Market, By Country
6.3.2 Europe Bluetooth-Enabled Market, By Country
Chapter 7. Europe Smart Insulin Pens Market, By End User
7.1 Europe Hospitals & Clinics Market, By Country
7.2 Europe Ambulatory Surgical Centers Market, By Country
7.3 Europe Home Care Settings Market, By Country
Chapter 8. Europe Smart Insulin Pens Market, By Country
8.1 Germany Smart Insulin Pens Market
8.1.1 Germany Smart Insulin Pens Market, By Usability
8.1.2 Germany Smart Insulin Pens Market, By Product
8.1.2.1 Germany Smart Insulin Pens Market, By Second Generation Pens Type
8.1.3 Germany Smart Insulin Pens Market, By End User
8.2 UK Smart Insulin Pens Market
8.2.1 UK Smart Insulin Pens Market, By Usability
8.2.2 UK Smart Insulin Pens Market, By Product
8.2.2.1 UK Smart Insulin Pens Market, By Second Generation Pens Type
8.2.3 UK Smart Insulin Pens Market, By End User
8.3 France Smart Insulin Pens Market
8.3.1 France Smart Insulin Pens Market, By Usability
8.3.2 France Smart Insulin Pens Market, By Product
8.3.2.1 France Smart Insulin Pens Market, By Second Generation Pens Type
8.3.3 France Smart Insulin Pens Market, By End User
8.4 Russia Smart Insulin Pens Market
8.4.1 Russia Smart Insulin Pens Market, By Usability
8.4.2 Russia Smart Insulin Pens Market, By Product
8.4.2.1 Russia Smart Insulin Pens Market, By Second Generation Pens Type
8.4.3 Russia Smart Insulin Pens Market, By End User
8.5 Spain Smart Insulin Pens Market
8.5.1 Spain Smart Insulin Pens Market, By Usability
8.5.2 Spain Smart Insulin Pens Market, By Product
8.5.2.1 Spain Smart Insulin Pens Market, By Second Generation Pens Type
8.5.3 Spain Smart Insulin Pens Market, By End User
8.6 Italy Smart Insulin Pens Market
8.6.1 Italy Smart Insulin Pens Market, By Usability
8.6.2 Italy Smart Insulin Pens Market, By Product
8.6.2.1 Italy Smart Insulin Pens Market, By Second Generation Pens Type
8.6.3 Italy Smart Insulin Pens Market, By End User
8.7 Rest of Europe Smart Insulin Pens Market
8.7.1 Rest of Europe Smart Insulin Pens Market, By Usability
8.7.2 Rest of Europe Smart Insulin Pens Market, By Product
8.7.2.1 Rest of Europe Smart Insulin Pens Market, By Second Generation Pens Type
8.7.3 Rest of Europe Smart Insulin Pens Market, By End User
Chapter 9. Company Profiles
9.1 Emperra GmbH
9.1.1 Company Overview
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Eli Lilly And Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Novo Nordisk A/S
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental & Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.5.2 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Jiangsu Delfu Medical Device Co.,Ltd
9.6.1 Company Overview
9.7 Abbott Laboratories
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Ypsomed AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Partnerships, Collaborations, and Agreements:

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us